71 – 80 of 102
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
HSP90 inhibition blocks ERBB3 and RET phosphorylation in myxoid/round cell liposarcoma and causes massive cell death in vitro and in vivo.
(
- Contribution to journal › Article
-
Mark
Dynamics of cytotoxic T cell subsets during immunotherapy predicts outcome in acute myeloid leukemia.
(
- Contribution to journal › Article
-
Mark
Aberrant epigenetic regulation in clear cell sarcoma of the kidney featuring distinct DNA hypermethylation and EZH2 overexpression.
(
- Contribution to journal › Article
-
Mark
Germline genetics of cancer of unknown primary (CUP) and its specific subtypes.
(
- Contribution to journal › Article
-
Mark
miR-124 downregulation leads to breast cancer progression via LncRNA-MALAT1 regulation and CDK4/E2F1 signal activation.
(
- Contribution to journal › Article
- 2015
-
Mark
Contrasting breast cancer molecular subtypes across serial tumor progression stages: biological and prognostic implications.
(
- Contribution to journal › Article
-
Mark
Multiple mechanisms of MYCN dysregulation in Wilms tumour.
(
- Contribution to journal › Article
-
Mark
Galiellalactone induces cell cycle arrest and apoptosis through the ATM/ATR pathway in prostate cancer cells.
2015) In Oncotarget(
- Contribution to journal › Article
-
Mark
MIR137 is an androgen regulated repressor of an extended network of transcriptional coregulators.
(
- Contribution to journal › Article
-
Mark
Myc-dependent purine biosynthesis affects nucleolar stress and therapy response in prostate cancer.
(
- Contribution to journal › Article